Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Sunyeob Hong, MD

Articles by Sunyeob Hong, MD

Two NYC-based musicians share their experiences during the pandemic with a resident.

Musicians’ Mental Health in the Empire City During COVID-19

BySunyeob Hong, MD

January 13th 2022

One resident interviews 2 NYC-based musicians about their experiences during the pandemic.

Latest Updated Articles

Trending on Psychiatric Times

New Data on Lumateperone for Prevention of Relapse in Schizophrenia

Phase 3 Data Support CT-155 as a Novel Digital Therapeutic for Negative Symptoms in Schizophrenia at ECNP

FDA Accepts NDA for CTx-1301 for Treatment of ADHD

Seltorexant Well-Tolerated in Adolescents as an Adjunct Treatment for Major Depressive Disorder

Women Are Diagnosed With ADHD 5 Years Later Than Men

© 2025 MJH Life Sciences^®

All rights reserved.